Literature DB >> 26612895

MYC in DLBCL: partners matter.

Elias Campo1.   

Abstract

In this issue of Blood, Copie-Bergman et al demonstrate that MYC rearrangements (MYC-Rs) with IG genes, but not with other partner genes, have a negative prognostic impact in patients with diffuse large B-cell lymphomas (DLBCLs) treated with immunochemotherapy.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26612895     DOI： 10.1182/blood-2015-10-671362

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  The 2016 revision of the World Health Organization classification of lymphoid neoplasms.

Authors:  Steven H Swerdlow; Elias Campo; Stefano A Pileri; Nancy Lee Harris; Harald Stein; Reiner Siebert; Ranjana Advani; Michele Ghielmini; Gilles A Salles; Andrew D Zelenetz; Elaine S Jaffe
Journal:  Blood       Date:  2016-03-15       Impact factor: 22.113

2.  Targeting ubiquitin-activating enzyme induces ER stress-mediated apoptosis in B-cell lymphoma cells.

Authors:  Scott Best; Taylor Hashiguchi; Adam Kittai; Nur Bruss; Cody Paiva; Craig Okada; Tingting Liu; Allison Berger; Alexey V Danilov
Journal:  Blood Adv       Date:  2019-01-08

Review 3.  Diagnosis and classification of hematologic malignancies on the basis of genetics.

Authors:  Justin Taylor; Wenbin Xiao; Omar Abdel-Wahab
Journal:  Blood       Date:  2017-06-09       Impact factor: 22.113

Review 4.  Clinical Impact of the 2016 Update to the WHO Lymphoma Classification.

Authors:  Ryan C Lynch; Dita Gratzinger; Ranjana H Advani
Journal:  Curr Treat Options Oncol       Date:  2017-07

5.  Distinct biological subtypes and patterns of genome evolution in lymphoma revealed by circulating tumor DNA.

Authors:  Florian Scherer; David M Kurtz; Aaron M Newman; Henning Stehr; Alexander F M Craig; Mohammad Shahrokh Esfahani; Alexander F Lovejoy; Jacob J Chabon; Daniel M Klass; Chih Long Liu; Li Zhou; Cynthia Glover; Brendan C Visser; George A Poultsides; Ranjana H Advani; Lauren S Maeda; Neel K Gupta; Ronald Levy; Robert S Ohgami; Christian A Kunder; Maximilian Diehn; Ash A Alizadeh
Journal:  Sci Transl Med       Date:  2016-11-09       Impact factor: 17.956

6.  Pharmacological modulation of CXCR4 cooperates with BET bromodomain inhibition in diffuse large B-cell lymphoma.

Authors:  Clara Recasens-Zorzo; Teresa Cardesa-Salzmann; Paolo Petazzi; Laia Ros-Blanco; Anna Esteve-Arenys; Guillem Clot; Martina Guerrero-Hernández; Vanina Rodríguez; Davide Soldini; Alexandra Valera; Alexandra Moros; Fina Climent; Eva González-Barca; Santiago Mercadal; Leonor Arenillas; Xavier Calvo; José Luís Mate; Gonzalo Gutiérrez-García; Isolda Casanova; Ramón Mangues; Alejandra Sanjuan-Pla; Clara Bueno; Pablo Menéndez; Antonio Martínez; Dolors Colomer; Roger Estrada Tejedor; Jordi Teixidó; Elias Campo; Armando López-Guillermo; José Ignacio Borrell; Luis Colomo; Patricia Pérez-Galán; Gaël Roué
Journal:  Haematologica       Date:  2018-06-28       Impact factor: 9.941

7.  An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens.

Authors:  Francesca Schieppati; Piera Balzarini; Simona Fisogni; Alessandro Re; Chiara Pagani; Nicola Bianchetti; Lorenzo Micheli; Angela Passi; Samantha Ferrari; Adriana Maifredi; Chiara Bottelli; Rossella Leopaldo; Vilma Pellegrini; Fabio Facchetti; Giuseppe Rossi; Alessandra Tucci
Journal:  Haematologica       Date:  2019-08-08       Impact factor: 9.941

8.  DCZ3301, a novel cytotoxic agent, inhibits proliferation in diffuse large B-cell lymphoma via the STAT3 pathway.

Authors:  Xi Sun; Bo Li; Bingqian Xie; Zhijian Xu; Gaomei Chang; Yi Tao; Yong Zhang; Shuaikang Chang; Yingcong Wang; Dandan Yu; Yongsheng Xie; Tingye Li; Houcai Wang; Gege Chen; Liangning Hu; Jun Hou; Yiwen Zhang; Wenqin Xiao; Lu Gao; Jumei Shi; Weiliang Zhu
Journal:  Cell Death Dis       Date:  2017-10-12       Impact factor: 8.469

9.  Transformation of Follicular Lymphoma to a High-Grade B-Cell Lymphoma With MYC and BCL2 Translocations and Overlapping Features of Burkitt Lymphoma and Acute Lymphoblastic Leukemia: A Case Report and Literature Review.

Authors:  Alina M Bischin; Russell Dorer; David M Aboulafia
Journal:  Clin Med Insights Blood Disord       Date:  2017-02-28

10.  Mutation of TP53, translocation analysis and immunohistochemical expression of MYC, BCL-2 and BCL-6 in patients with DLBCL treated with R-CHOP.

Authors:  Pekka Peroja; Mette Pedersen; Tuomo Mantere; Peter Nørgaard; Jenni Peltonen; Kirsi-Maria Haapasaari; Jan Böhm; Esa Jantunen; Taina Turpeenniemi-Hujanen; Katrin Rapakko; Peeter Karihtala; Ylermi Soini; Kaija Vasala; Outi Kuittinen
Journal:  Sci Rep       Date:  2018-10-04       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.